Scientists create personal Mini-Livers to outsmart cancer drugs
NCT ID NCT05384184
First seen Nov 20, 2025 · Last updated Jun 16, 2026 · Updated 22 times
Summary
This study collected leftover liver tissue from 48 adults with colorectal cancer that spread to the liver or with liver cancer. The goal was to grow tiny 3D mini-livers (organoids) in the lab to create a biobank for future drug testing. This research does not offer a treatment but aims to build a better model for predicting which drugs will work for each patient.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER METASTASES AND HEPATOCELLULAR CARCINOMAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ap-HM hopital nord
Marseille, 13915, France
Conditions
Explore the condition pages connected to this study.